Holocene Advisors, LP Gilead Sciences, Inc. Transaction History

Holocene Advisors, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.48 Million - $1.67 Million	-25,713 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.49 Million - $1.87 Million	25,713 New	25,713 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $129 Million - $141 Million	-2,038,262 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $48.7 Million - $55.6 Million	811,897 Added 66.2%	2,038,262 $132 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $69.5 Million - $79.2 Million	1,226,365 New	1,226,365 $71.4 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $215,142 - $250,954	-3,316 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $446,290 - $544,077	-6,127 Reduced 64.88%	3,316 $250,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $671,869 - $788,679	9,443	9,443 $676,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.